Report-based arterial FDG uptake and the NAFLD–atherosclerosis overlap phenotype: a two-centre cross-sectional PET/CT study with an exploratory decomposition of the hepatic FDG signal

Background Qualitative arterial fluorodeoxyglucose (FDG) uptake descriptions in routine positron emission tomography/computed tomography (PET/CT) reports may contain information relevant to cardiometabolic disease. We examined their association with coexisting non-alcoholic fatty liver disease ( N AFLD) and atherosclerosis, and whether report-based hepatic FDG uptake statistically accounted for this association. Methods This retrospective cross-sectional study included 556 adults from two Chinese centres (Xiamen, n = 222; Xiangya, n = 334). Arterial FDG uptake was graded from 0 to 3 using routine reports. Four mutually exclusive phenotypes (neither condition, NAFLD only, atherosclerosis only and overlap) were ascertained independently of PET uptake. Centre-specific multinomial logistic regression assessed associations per one-grade increase. The clinically adjusted model was primary, and its stability was checked by bootstrap and penalised likelihood. Full adjustment in 471 participants served as a saturation test. Pairwise contrasts compared phenotype-specific associations. Exploratory cross-sectional decomposition evaluated hepatic FDG uptake as a statistical intermediate. Results Among participants with NAFLD, 99.4% met at least one cardiometabolic criterion for metabolic dysfunction-associated steatotic liver disease (MASLD). Higher arterial grades were associated with the overlap phenotype in both centres (adjusted odds ratio [OR] 2.23, 95% confidence interval [CI] 1.49–3.34 in Xiamen; OR 1.83, 95% CI 1.37–2.46 in Xiangya). Bootstrap, penalised and fully adjusted estimates were consistent. Associations were stronger for overlap than for either condition alone, but there was no evidence that the overlap association exceeded the combined single-condition associations on the log-odds scale. No exposure-by-centre interaction was detected ( P = 0.622). Hepatic uptake statistically accounted for 11.0% (Xiamen) and 21.1% (Xiangya) of the total association, and the indirect-component CI included the null in Xiamen. This component disappeared when the outcome excluded the hepatic condition. Alternative exposure definitions and sensitivity analyses, including selection and reporting-bias analyses, supported the primary association. Conclusions Report-based arterial FDG uptake grades were associated with coexisting NAFLD and atherosclerosis across two centres. The hepatic component largely reflected steatosis-related construct overlap, although a shared metabolic substrate such as insulin resistance cannot be excluded. These hypothesis-generating findings support further investigation of routine report text for opportunistic cardiometabolic phenotyping but do not establish causality or clinical utility.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-17
DOI
https://doi.org/10.3389/fcvm.2026.1989672
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Report-based arterial FDG uptake and the NAFLD–atherosclerosis overlap phenotype: a two-centre cross-sectional PET/CT study with an exploratory decomposition of the hepatic FDG signal

Liang Xu, Qun Fan, Hong Zhang, Chao Ma et al.
Frontiers in Cardiovascular Medicine
Liver Disease Diagnosis and Treatment
article

Report-based arterial FDG uptake and the NAFLD–atherosclerosis overlap phenotype: a two-centre cross-sectional PET/CT study with an exploratory decomposition of the hepatic FDG signal

Liang Xu, Qun Fan, Hong Zhang, Chao Ma, Fu Su
article en

Abstract

Background Qualitative arterial fluorodeoxyglucose (FDG) uptake descriptions in routine positron emission tomography/computed tomography (PET/CT) reports may contain information relevant to cardiometabolic disease. We examined their association with coexisting non-alcoholic fatty liver disease ( N AFLD) and atherosclerosis, and whether report-based hepatic FDG uptake statistically accounted for this association. Methods This retrospective cross-sectional study included 556 adults from two Chinese centres (Xiamen, n = 222; Xiangya, n = 334). Arterial FDG uptake was graded from 0 to 3 using routine reports. Four mutually exclusive phenotypes (neither condition, NAFLD only, atherosclerosis only and overlap) were ascertained independently of PET uptake. Centre-specific multinomial logistic regression assessed associations per one-grade increase. The clinically adjusted model was primary, and its stability was checked by bootstrap and penalised likelihood. Full adjustment in 471 participants served as a saturation test. Pairwise contrasts compared phenotype-specific associations. Exploratory cross-sectional decomposition evaluated hepatic FDG uptake as a statistical intermediate. Results Among participants with NAFLD, 99.4% met at least one cardiometabolic criterion for metabolic dysfunction-associated steatotic liver disease (MASLD). Higher arterial grades were associated with the overlap phenotype in both centres (adjusted odds ratio [OR] 2.23, 95% confidence interval [CI] 1.49–3.34 in Xiamen; OR 1.83, 95% CI 1.37–2.46 in Xiangya). Bootstrap, penalised and fully adjusted estimates were consistent. Associations were stronger for overlap than for either condition alone, but there was no evidence that the overlap association exceeded the combined single-condition associations on the log-odds scale. No exposure-by-centre interaction was detected ( P = 0.622). Hepatic uptake statistically accounted for 11.0% (Xiamen) and 21.1% (Xiangya) of the total association, and the indirect-component CI included the null in Xiamen. This component disappeared when the outcome excluded the hepatic condition. Alternative exposure definitions and sensitivity analyses, including selection and reporting-bias analyses, supported the primary association. Conclusions Report-based arterial FDG uptake grades were associated with coexisting NAFLD and atherosclerosis across two centres. The hepatic component largely reflected steatosis-related construct overlap, although a shared metabolic substrate such as insulin resistance cannot be excluded. These hypothesis-generating findings support further investigation of routine report text for opportunistic cardiometabolic phenotyping but do not establish causality or clinical utility.

Frontiers in Cardiovascular MedicineVol. 13
Fujian Medical University (CN), Xiamen University (CN), Zhongshan Hospital of Xiamen University (CN), Second Xiangya Hospital of Central South University (CN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon